mRNA COVID-19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta-analysis

Eur J Haematol. 2022 Mar;108(3):264-267. doi: 10.1111/ejh.13729. Epub 2021 Dec 13.

Authors

Stefano Molica¹, Diana Giannarelli², Emili Montserrat³

Affiliations

¹ Department Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy.
² Biostatistic Unit, IRCCS Regina Elena, Rome, Italy.
³ Department of Hematology, Hospital Clinic, University of Barcelona, Barcelona, Spain.

PMID: 34856031
DOI: 10.1111/ejh.13729

No abstract available

Keywords: chronic lymphocytic leukemia; mRNA SARS-CoV-2 vaccine; meta-analysis; systematic review; treatment status.

Publication types

Letter
Meta-Analysis
Systematic Review

MeSH terms

Antibodies, Viral / blood
COVID-19 / immunology
COVID-19 / prevention & control*
COVID-19 / virology
COVID-19 Vaccines / administration & dosage*
COVID-19 Vaccines / immunology
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
RNA, Messenger / genetics*
SARS-CoV-2 / immunology
SARS-CoV-2 / isolation & purification
mRNA Vaccines / administration & dosage*
mRNA Vaccines / immunology

Substances

Antibodies, Viral
COVID-19 Vaccines
RNA, Messenger
mRNA Vaccines